Revenue and Earnings - The company's revenue for Q1 2024 was ¥4,146,570.04, representing a decrease of 84.49% compared to ¥26,729,590.70 in the same period last year[5] - Total operating revenue for Q1 2024 was CNY 4,146,570.04, a decrease of 84.5% compared to CNY 26,729,590.70 in the same period last year[19] - The net loss attributable to shareholders was ¥9,589,801.69, an improvement of 26.82% from a loss of ¥13,104,546.15 in the previous year[5] - Net loss for Q1 2024 was CNY 9,894,903.32, an improvement from a net loss of CNY 13,104,546.15 in Q1 2023, representing a 24.5% reduction in losses[20] - Basic and diluted earnings per share were both -¥0.0959, showing a 26.79% improvement from -¥0.1310 in the same period last year[5] - The basic and diluted earnings per share for Q1 2024 were both negative CNY 0.0959, compared to negative CNY 0.1310 in Q1 2023[21] Operating Costs and Expenses - The company reported a significant decrease in revenue due to reduced product acceptance, leading to a corresponding decrease in operating costs by 84.96% to ¥3,467,362.84[8] - Total operating costs for Q1 2024 were CNY 13,334,627.74, down 64.8% from CNY 37,858,382.92 year-over-year[19] - Research and development expenses decreased by 67.10% to ¥314,903.72, indicating reduced investment in R&D activities[8] - Research and development expenses decreased to CNY 314,903.72 from CNY 957,261.42, a reduction of 67.1% year-over-year[19] - The company reported a significant increase in sales expenses to CNY 2,060,935.97, up from CNY 973,874.57 year-over-year, reflecting a 111.2% increase[19] Cash Flow and Financial Position - Cash flow from operating activities was -¥39,158,753.99, a slight increase in outflow of 2.16% compared to -¥38,329,126.49 in the previous year[5] - Operating cash flow for Q1 2024 was negative CNY 39,158,753.99, slightly worse than negative CNY 38,329,126.49 in the previous year[24] - Cash flow from investing activities showed a net outflow of -¥26,422,833.00, which is a 43.98% increase in outflow compared to -¥18,351,601.77 in the previous year[9] - The net cash flow from financing activities was -1,419,704.00 CNY, indicating a decrease compared to the previous period's -111,456.00 CNY[25] - The net increase in cash and cash equivalents for the period was -67,001,290.99 CNY, down from -56,794,105.05 CNY in the previous period[25] - The ending balance of cash and cash equivalents was 9,007,322.38 CNY, significantly lower than the previous period's 62,913,691.80 CNY[25] Assets and Liabilities - Total assets decreased by 10.35% to ¥315,533,229.63 from ¥351,975,356.84 at the end of the previous year[5] - Total current assets decreased from 297,085,371.23 CNY to 237,794,712.94 CNY, a reduction of approximately 20%[15] - Accounts receivable decreased from 85,616,559.98 CNY to 78,877,393.03 CNY, a decline of about 8%[14] - Inventory increased from 72,477,370.50 CNY to 75,166,719.15 CNY, an increase of approximately 9%[15] - Total liabilities decreased from 74,737,922.32 CNY to 48,190,698.43 CNY, a decline of approximately 36%[16] - The total equity remains unchanged at 100,000,000.00 CNY[16] - The company reported a total equity attributable to shareholders of CNY 265,918,617.99, down from CNY 275,508,419.68 in the previous quarter[20] - The total liabilities and equity amounted to CNY 315,533,229.63, a decrease from CNY 351,975,356.84 in the previous quarter[20] Shareholder Information - Total number of common shareholders at the end of the reporting period is 5,188[11] - The largest shareholder, Shenzhen Fengqi Zhi Yuan Technology Co., Ltd., holds 16.00% of shares, amounting to 16,000,000 shares, with 11,304,237 shares pledged and 7,873,763 shares frozen[11] Other Developments - The company has not reported any new product or technology developments in the current quarter[12] - There are no significant mergers or acquisitions reported during this period[12] - The company reported a significant reduction in accounts receivable impairment losses by 78.17%, amounting to -¥448,261.24 compared to -¥2,053,513.62 in the previous year[8] - The company incurred a financial expense of CNY 200,612.12, which increased from CNY 146,417.83 in the same period last year[19]
*ST和科(002816) - 2024 Q1 - 季度财报